Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-03 Sale |
2025-03-05 8:00 pm |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
3,334 | $32.15 | $107,174 | 176,138 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-05 8:00 pm |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
3,334 | $42.29 | $140,999 | 179,472 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-03 5:10 pm |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
13,334 | $54.88 | $731,785 | 145,139 (Direct) |
View |
| 2024-09-27 Sale |
2024-09-27 7:32 pm |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
50,000 | $45.96 | $2,297,755 | 168,259 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Exercise |
2025-03-05 8:00 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
3,334 | $4.21 | 176,138 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 8:00 pm |
N/A 2031-03-09 |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
3,334 | $0 | 176,138 (Direct) |
View |
| 2025-02-03 Exercise |
2025-02-05 8:00 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
3,334 | $4.21 | 179,472 (Direct) |
View |
| 2025-02-03 Exercise |
2025-02-05 8:00 pm |
N/A 2031-03-09 |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
3,334 | $0 | 179,472 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 5:10 pm |
N/A 2035-01-01 |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
81,000 | $0 | 145,139 (Direct) |
View |
| 2024-12-19 Exercise |
2024-12-20 6:25 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
1 | $14.02 | 264,342 (Direct) |
View |
| 2024-12-19 Exercise |
2024-12-20 6:25 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
9,880 | $20.24 | 264,342 (Direct) |
View |
| 2024-12-19 Exercise |
2024-12-20 6:25 pm |
N/A 2032-01-02 |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
9,881 | $0 | 264,342 (Direct) |
View |
| 2024-09-27 Exercise |
2024-09-27 7:32 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
50,000 | $4.21 | 168,259 (Direct) |
View |
| 2024-09-27 Exercise |
2024-09-27 7:32 pm |
N/A 2031-03-09 |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
50,000 | $0 | 168,259 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-03 4:50 pm |
N/A 2034-01-01 |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:33 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:26 pm |
N/A 2032-01-02 |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
106,750 | $0 | 106,750 (Direct) |
View |
Ownership |
2021-06-10 7:15 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
0 | $0 | 338,183 (Direct) |
View |